Why the study?
The study evaluated the effect of adenosine on mechanisms sustaining persistent AF using contact electrograms and non-invasive ECGI mapping.
Does intravenous adenosine alter the burden, distribution, or characteristics of potential drivers sustaining persistent atrial fibrillation?
Does intravenous adenosine alter the burden, distribution, or characteristics of potential drivers sustaining persistent atrial fibrillation?
Intravenous adenosine shortens atrial cycle length, particularly in the right atrium, but does not significantly alter the overall burden or distribution of potential drivers in persistent atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports adenosine to facilitate ECGI mapping of persistent AF; leaves open confirmation by other modalities and any impact on ablation targeting.
BACKGROUND: We evaluated the effect of adenosine upon mechanisms sustaining persistent AF through analysis of contact electrograms and ECGI mapping. METHODS: Persistent AF patients undergoing catheter ablation were included. ECGI maps and cycle length (CL) measurements were recorded in the left and right atrial appendages and repeated following boluses of 18 mg of intravenous adenosine. Potential drivers (PDs) were defined as focal or rotational activations completing ≥ 1.5 revolutions. Distribution of PDs was assessed using an 18 segment biatrial model. RESULTS: 46 patients were enrolled. Mean age was 63.4 ± 9.8 years with 33 (72%) being male. There was no significant difference in the number of PDs recorded at baseline compared to adenosine (42.1 ± 15.2 vs 40.4 ± 13.0; p = 0.417), nor in the number of segments harbouring PDs, (13 (11-14) vs 12 (10-14); p = 0.169). There was a significantly higher percentage of PDs that were focal in the adenosine maps (36.2 ± 15.2 vs 32.2 ± 14.4; p < 0.001). There was a significant shortening of CL in the adenosine maps compared to baseline which was more marked in the right atrium than left atrium (176.7 ± 34.7 vs 149.9 ± 27.7 ms; p < 0.001 and 165.6 ± 31.7 vs 148.3 ± 28.4 ms; p = 0.003). CONCLUSION: Adenosine led to a small but significant shortening of CL which was more marked in the right than left atrium and may relate to shortening of refractory periods rather than an increase in driver burden or distribution. Registered on Clinicaltrials.gov: NCT03394404.
No takes yet. Share an insight, caveat, or question.
Dhillon et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: